- Home
- GNLX vs IGA Comparison
GNLX vs IGA Comparison
Compare GNLX & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- IGA
- Stock Information
- Founded
- GNLX 2001
- IGA 2005
- Country
- GNLX United States
- IGA United States
- Employees
- GNLX N/A
- IGA N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- IGA Investment Managers
- Sector
- GNLX Health Care
- IGA Finance
- Exchange
- GNLX Nasdaq
- IGA Nasdaq
- Market Cap
- GNLX 128.0M
- IGA 151.6M
- IPO Year
- GNLX 2023
- IGA N/A
- Fundamental
- Price
- GNLX $5.90
- IGA $9.64
- Analyst Decision
- GNLX Strong Buy
- IGA
- Analyst Count
- GNLX 4
- IGA 0
- Target Price
- GNLX $19.75
- IGA N/A
- AVG Volume (30 Days)
- GNLX 350.8K
- IGA 42.3K
- Earning Date
- GNLX 11-05-2025
- IGA 01-01-0001
- Dividend Yield
- GNLX N/A
- IGA 8.93%
- EPS Growth
- GNLX N/A
- IGA N/A
- EPS
- GNLX N/A
- IGA N/A
- Revenue
- GNLX N/A
- IGA N/A
- Revenue This Year
- GNLX N/A
- IGA N/A
- Revenue Next Year
- GNLX N/A
- IGA N/A
- P/E Ratio
- GNLX N/A
- IGA N/A
- Revenue Growth
- GNLX N/A
- IGA N/A
- 52 Week Low
- GNLX $1.99
- IGA $7.77
- 52 Week High
- GNLX $8.54
- IGA $8.88
- Technical
- Relative Strength Index (RSI)
- GNLX 45.83
- IGA 42.19
- Support Level
- GNLX $4.34
- IGA $9.50
- Resistance Level
- GNLX $6.12
- IGA $9.64
- Average True Range (ATR)
- GNLX 0.85
- IGA 0.10
- MACD
- GNLX -0.32
- IGA -0.01
- Stochastic Oscillator
- GNLX 36.41
- IGA 48.11
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest
Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.